Apr 27, 2017 - ImmunoGen shareholders have suffered losses for decades. Where is the light at the end of this tunnel?
Apr 26, 2017 - Merck & Co., Inc. (MRK) will be reporting first-quarter 2017 earnings on May 2, before market opens. Last quarter, the company delivered a positive earnings surprise of 1.14%.
Apr 25, 2017 - Has the market overestimated the odds of success for Tesaro's fancy new cancer drug?
Apr 25, 2017 - Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.
Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
Apr 25, 2017 - Which drug stock wins in a head-to-head matchup between Celgene and Merck?
Apr 25, 2017 - These healthcare, bank, and tech companies are leading the way in investing in global change.
Apr 24, 2017 - The deadly Ebola outbreak in West Africa two years ago, the worst in recorded history, led to a vaccine that seemingly would stop the next Ebola epidemic in its tracks. Now there are questions about that claim.
Apr 24, 2017 - The last week of April is scheduled to see eight different companies go public, and Zacks has you covered with three unique IPO offerings to watch out for.
Apr 24, 2017 - The combination of big tech and healthcare may be an unlikely matchup, but as these collaborations become more prevalent, patients will be the ultimate beneficiaries.